|
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
_____________
|
||
|
SCHEDULE
13G
(RULE
13d-102)
|
||
|
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED
PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND
AMENDMENTS
THERETO FILED PURSUANT TO RULE 13d-2(b)
___________
|
||
|
(Amendment
No. 2)*
|
||
|
ACADIA
PHARMACEUTICALS INC.
|
||
|
(Name
of Issuer)
|
||
|
Common
Stock, par value $0.0001
|
004225108 | |
|
(Title
of class of securities)
|
(CUSIP
number)
|
|
|
December
31, 2009
|
||
|
(Date
of Event Which Requires Filing of this
Statement)
|
||
|
Check
the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|
|
|
¨
|
Rule
13d-1(b)
|
|
¨
|
Rule
13d-1(c)
|
|
x
|
Rule
13d-1(d)
|
|
__________
|
|
|
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover
page.
|
|
|
The
information required in the remainder of this cover page shall not be
deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
|
|
|
Continued
on Following Pages
Page
1 of 6
|
|
|
CUSIP
No.
|
004225108
|
13G
|
Page
2 of 6
|
|||
|
1
|
NAME
OF REPORTING PERSONS:
|
Nomura
International plc on behalf of
Nomura
Phase4 Ventures LP, Nomura Phase4 GP Limited and Nomura Phase4
Ventures Limited
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP:*
|
(a)
[ ]
(b)
[X]
|
||||
|
3
|
SEC
USE ONLY
|
|||||
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION:
|
England
and Wales
|
||||
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH
|
5
|
SOLE
VOTING POWER:
|
Shares
of Common Stock: 0
Warrants
to purchase Common Stock: 549,752
|
|||
|
6
|
SHARED
VOTING POWER:
|
0
|
||||
|
7
|
SOLE
DISPOSITIVE POWER:
|
Shares
of Common Stock: 0
Warrants
to purchase Common Stock: 549,752
|
||||
|
8
|
SHARED
DISPOSITIVE POWER:
|
0
|
||||
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
|
Shares
of Common Stock: 0
Warrants
to purchase Common Stock: 549,752
|
||||
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES:*
|
[ ]
|
||||
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
|
1.4%
|
||||
|
12
|
TYPE
OF REPORTING PERSON:
|
CO,
OO
|
||||
|
ITEM
1.
|
NAME
OF ISSUER AND ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE
OFFICES
|
|
ITEM
2.
|
NAME
OF PERSON FILING
|
|
ITEM
3.
|
IF
THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), OR 13d-2(b) OR (c),
CHECK WHETHER THE PERSON FILING IS:
|
|
ITEM
4.
|
OWNERSHIP
|
|
ITEM
5.
|
OWNERSHIP
OF FIVE PERCENT OR LESS OF A CLASS
|
|
ITEM
6.
|
OWNERSHIP
OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON
|
|
ITEM
7.
|
IDENTIFICATION
AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING
REPORTED ON BY THE PARENT HOLDING
COMPANY
|
|
ITEM
8.
|
IDENTIFICATION AND
CLASSIFICATION OF MEMBERS OF THE
GROUP.
|
|
ITEM
9.
|
NOTICE
OF DISSOLUTION OF GROUP
|
|
ITEM
10.
|
CERTIFICATION
|
|
Date
|
February
12, 2010
|
|||
|
NOMURA
INTERNATIONAL PLC
|
||||
|
By:
|
/s/ Denise Pollard-Knight | |||
|
Name:
|
Denise Pollard-Knight | |||
|
Title:
|
Managing Director | |||